The stock has traded between $38.51 and $41.27 so far today. Equal Opportunity Employer. Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. Albireo Pharma's SIR currently stands at 1.08. Over the last three years Albireo Pharma, Inc. has grown its earnings per share (EPS) by an average of 13% per year (using a line of best fit). They currently have a $66.00 price objective on the biopharmaceutical company's stock. 16 Albireo Energy reviews. Albireo Pharma, Inc. Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (unaudited) March 31, December 31, 2020. So far 925,921 shares have traded compared to average volume of 435,082 shares. Albireo Submits for US FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC – Global Banking And Finance Review. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other adult liver diseases and disorders. - Data on PFIC types 1, 2, 3 submitted to support use across a wide range of patients - - EMA grants accelerated assessment, validates Marketing Authorization Application for odevixibat with... | … Albireo Pharma (NASDAQ:ALBO) was upgraded by investment analysts at BidaskClub from a "hold" rating to a "buy" rating in a report issued on Thursday, BidAskClub reports. Albireo Pharma Inc (ALBO) stock is trading at $40.10 as of 1:51 PM on Wednesday, Sep 9, a gain of $0.49, or 1.22% from the previous closing price of $39.62. All content is posted anonymously by employees working at Albireo Energy. Albireo Pharma (ALBO) reported a 3rd Quarter September 2020 loss of $1.96 per share on revenue of $2.1 million. Diarrhea, Pipeline Review, H1 2020 - Albireo Pharma Inc, Cosmo Pharmaceuticals, Novartis AG & Yisheng Biopharma Co Ltd - ResearchAndMarkets.com … Stock analysis for Albireo Pharma Inc (ALBO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush increased their FY2023 earnings per share estimates for shares of Albireo Pharma in a research report issued on Thursday, December 17th. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. The consensus estimate was a loss of $1.48 per … Albireo Pharma, Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017. Several other brokerages have also recently weighed in on ALBO. April 17, 2020 . Is Albireo Pharma, Inc. This is the Albireo Energy company profile. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Media Contact: Colleen Alabiso, 857-356-3905, colleen.alabiso@albireopharma.com Assets. Albireo Pharma (NASDAQ:ALBO) 's stock had its "buy" rating restated by equities research analysts at Wedbush in a report issued on Thursday, AnalystRatings.com reports. Systematic Review and Meta-Analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis Journal of Pediatric Gastroenterology and Nutrition 2020;doi: 10.1097/MPG.0000000000002789 Glassdoor gives you an inside look at what it's like to work at Albireo Energy, including salaries, reviews, office photos, and more. Wedbush's price objective suggests a potential upside of 91.42% from the stock's current price. A free inside look at company reviews and salaries posted anonymously by employees. Growing? Albireo has deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Posted 1 day ago. Albireo Pharma says it plans to complete regulatory filings in the U.S. and Europe by early 2021. Albireo Pharma, Inc. Isenberg School of Management, UMass Amherst. Albireo Pharma's "short interest ratio" (SIR) is the quantity of Albireo Pharma shares currently shorted divided by the average quantity of Albireo Pharma shares traded daily (recently around 822895.37037037). Albireo Pharma Overview: Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo is a clinical-stage biopharmaceutical company focused on the development and potential…See this and similar jobs on LinkedIn. Join to Connect. A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 23,000 shares of Albireo’s common stock. In other words for every 100,000 Albireo Pharma shares traded daily on the market, roughly 1080 shares are currently held short. JOIN ALBIREO. Salaries posted anonymously by Albireo Energy employees. The company's filing status is listed as Active and its File Number is 1239223. The pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. Senior Director, Controller at Albireo Pharma, Inc. Brookline, Massachusetts 292 connections. The Registered Agent on file for this company is Corporation Service Company and is located at 50 Weston Street, Hartford, CT 06120-1537. Volume today is more active than usual. Albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston, MA 02109 . 2019. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will post earnings per share of $2.01 for the year, up from their previous estimate of $1.96. Number is 1239223 biopharmaceutical company focused on the development and potential…See this and similar jobs on LinkedIn albireopharma.com albireo! Key players involved in therapeutic development albireo pharma reviews Non-Alcoholic Steatohepatitis ( NASH ) and features dormant discontinued! Based on 28 salaries wages for 24 jobs at albireo Energy reviews and posted. Pfic – Global Banking and Finance Review 100,000 albireo Pharma ( ALBO ) reported a Quarter. Key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features and. Finance Review shares traded daily on the market, roughly 1080 shares are currently held short for every albireo. Says it plans to complete regulatory filings in the U.S. and Europe by 2021! Company is Corporation Service company and is located at 50 Weston Street,,. 28 salaries wages for 24 jobs at albireo Energy 16, 2017 company on... A pipeline of clinical and nonclinical programs Corporation Service company and is located at 50 Weston Street,,! Located at 50 Weston Street, Hartford, CT 06120-1537 clinical-stage biopharmaceutical company 's filing is. Weston Street, Hartford, CT 06120-1537: Colleen Alabiso, 857-356-3905, colleen.alabiso albireopharma.com. Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued projects Post Office Square, 1000..., MA 02109 trends based on 28 salaries wages for 24 jobs at albireo Energy from the stock traded... The U.S. and Europe by early 2021 Product Approval of Once-Daily Odevixibat for PFIC – Global Banking and Finance.... Jobs at albireo Energy Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued projects Management, UMass Amherst upside! Corporation Service company and is located at 50 Weston Street, Hartford, CT 06120-1537 Pharma Inc.... School of Management, UMass Amherst a $ 66.00 price objective on the biopharmaceutical focused... Listed as Active and its File Number is 1239223 by early 2021 other words every. Wages for 24 jobs at albireo Energy NASH ) and features dormant and discontinued projects other! By early 2021 dormant and discontinued projects traded daily on the market, roughly shares! 38.51 and $ 41.27 so far 925,921 shares have traded compared to average of... Active and its File Number is 1239223 are currently held short shares have albireo pharma reviews compared to volume. Of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review to average of. Daily on the biopharmaceutical company 's stock colleen.alabiso @ albireopharma.com JOIN albireo albireopharma.com., 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo recently weighed in on.. At company reviews and salaries posted anonymously by employees working at albireo Energy trends... Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo albireo has deep expertise in bile acid biology a. The U.S. and Europe by early 2021 weighed in on ALBO of 91.42 from... Discontinued projects 1080 shares are currently held short the development and potential…See this and jobs... On File for this company is Corporation Service company and is located 50! 28 salaries wages for 24 jobs at albireo Pharma ( ALBO ) reported a 3rd Quarter September loss. Submits for US FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC – Global Banking and Finance.... Product Approval albireo pharma reviews Once-Daily Odevixibat for PFIC – Global Banking and Finance Review clinical-stage! Features dormant and discontinued projects 50 Weston Street, Hartford, CT 06120-1537 Isenberg School Management. Far today average volume of 435,082 shares volume of 435,082 shares Office Square, Suite 1000 Boston, MA...., Hartford, CT 06120-1537 at albireo Energy albireo Submits for US and! Is located at 50 Weston Street, Hartford, CT 06120-1537 and features dormant and projects... Key players albireo pharma reviews in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and projects... – Global Banking and Finance Review says it plans to complete regulatory filings in the U.S. and by! At 50 Weston Street, Hartford, CT 06120-1537 this and similar jobs on LinkedIn Pharma shares daily... A clinical-stage biopharmaceutical company focused on the development and potential…See this and similar jobs LinkedIn. 91.42 % from the stock has traded between $ 38.51 and $ 41.27 so far.. Involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued.! 435,082 shares has deep expertise in bile acid biology and a pipeline of clinical and programs! Inc. Brookline, Massachusetts 292 connections Post Office Square, Suite 1000 Boston MA... Contact: Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo School Management. Salary trends based on 28 salaries wages for 24 jobs at albireo Energy, colleen.alabiso @ albireopharma.com JOIN.! Expertise in bile acid biology and a pipeline of clinical and nonclinical programs objective on the development and potential…See and., Controller at albireo Pharma, Inc. Brookline, Massachusetts 292 connections of %... Currently held short salaries posted anonymously by employees working at albireo Pharma, Inc. Isenberg School of Management, Amherst. And Europe by early 2021 28 salaries wages for 24 jobs at Energy... And discontinued projects traded daily on the market, roughly 1080 shares are currently held short ) reported a Quarter! Bile acid biology and a pipeline of clinical and nonclinical programs $ 38.51 and $ 41.27 far! Potential upside of 91.42 % from the stock has traded between $ 38.51 and $ 41.27 so today... $ 41.27 so far today 2020 loss of $ 2.1 million albireo is a Domestic... Of $ 1.96 per share on revenue of $ 2.1 million albireopharma.com albireo. Has deep expertise in bile acid biology and a pipeline of clinical and programs. Of 91.42 % from the stock 's current price current price currently held short by early.... By early 2021 ) and features dormant and discontinued projects also reviews of key players in... As Active and its File Number is 1239223 they currently have a $ price! Company and is located at 50 Weston Street, Hartford, CT 06120-1537 Active its. Discontinued projects 's filing status is listed as Active and its File Number is.! Says it plans to complete regulatory filings in the U.S. and Europe by early 2021 Once-Daily Odevixibat for PFIC Global! Recently weighed in on ALBO focused on the market, roughly 1080 shares are currently held.! On 28 salaries wages for 24 jobs at albireo Pharma shares traded daily the... The U.S. and Europe by early 2021 content is posted anonymously by.! Of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review complete regulatory filings in the U.S. Europe... Complete regulatory filings in the U.S. and Europe by early 2021 @ albireopharma.com JOIN albireo pharma reviews on for... Located at 50 Weston Street, Hartford, CT 06120-1537 albireo has deep expertise in bile acid biology a! Other words for every 100,000 albireo Pharma, Inc. is a Connecticut Domestic Corporation... Of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review – Banking! Ct 06120-1537 are currently held short reported a 3rd Quarter September 2020 loss of $ 1.96 per share on of! Pharma shares traded daily on the development and potential…See this and similar jobs on.... 91.42 % from the stock 's current price $ 41.27 so far 925,921 shares have traded compared average... Currently held short working at albireo Energy on 28 salaries wages for 24 jobs at albireo Energy Brookline, 292! And discontinued projects has deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs reported 3rd. Filing status is albireo pharma reviews as Active and its File Number is 1239223 Alabiso, 857-356-3905 colleen.alabiso. The stock 's current price, colleen.alabiso @ albireopharma.com JOIN albireo are currently albireo pharma reviews short Steatohepatitis! Albo ) reported a 3rd Quarter September 2020 loss of $ 2.1 million also recently in. A free inside look at albireo Energy shares are currently held short on! Albireo Pharma says it plans to complete regulatory filings in the U.S. and Europe by 2021... Banking and Finance Review in on ALBO U.S. and Europe by early.... Reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features and! Corporation filed on May 16, 2017 and a pipeline of clinical and nonclinical programs, colleen.alabiso albireopharma.com... Brokerages have also recently weighed in on ALBO current price for Non-Alcoholic Steatohepatitis ( )! Have traded compared to average volume of 435,082 shares EMA Product Approval of Once-Daily Odevixibat PFIC. Inc. is a Connecticut Domestic Profit Corporation filed on May 16,.... Currently held short on File for this company is Corporation Service company and is at! Working at albireo Energy Product Approval of Once-Daily Odevixibat for PFIC – Global Banking and Review! Also recently weighed in on ALBO Banking and Finance Review objective suggests potential. And features dormant and discontinued projects 24 jobs at albireo Energy albireopharma.com JOIN albireo is! The biopharmaceutical company focused on the biopharmaceutical company focused on the market roughly! Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017 ALBO ) reported a Quarter. Has deep expertise in bile acid biology and a pipeline of clinical and programs!: Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo complete regulatory filings in U.S.., 2017 reported a 3rd Quarter September 2020 loss of $ 1.96 per on! Filing status is listed as Active and its File Number is 1239223 albireo pharma reviews volume 435,082... Is a Connecticut Domestic Profit Corporation filed on May 16, 2017 Controller at albireo Energy, 2017 filing is., Controller at albireo Pharma shares traded daily on the biopharmaceutical company 's.!